<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H585664BCA5FF4C9E93D1C977BB518BF2" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>119 HR 5629 IH: To provide that the final rule of the Department of Health and Human Services titled “Medications for the Treatment of Opioid Use Disorder”, except for the portion of the final rule relating to accreditation of opioid treatment programs, shall have no force or effect.</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2025-09-30</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">119th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 5629</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20250930">September 30, 2025</action-date><action-desc><sponsor name-id="H001093">Mrs. Houchin</sponsor> introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To provide that the final rule of the Department of Health and Human Services titled <quote>Medications for the Treatment of Opioid Use Disorder</quote>, except for the portion of the final rule relating to accreditation of opioid treatment programs, shall have no force or effect.</official-title></form><legis-body id="H6B481193B7F14589B45768BB38F9AE47" style="OLC"> 
<section id="HDBE5AD3830E9402499E062F5649A84F5" section-type="section-one"><enum>1.</enum><header>Rule relating to medications for the treatment of opioid use disorder</header>
<subsection id="HE78C494BAAEC4B68B6210549AFD7FCA1"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">Except as provided by subsection (b), the final rule of the Department of Health and Human Services titled <quote>Medications for the Treatment of Opioid Use Disorder</quote> (89 Fed. Reg. 7549; published February 2, 2024) shall have no force or effect.</text></subsection> <subsection id="H7F86EDC7C4FB46DAA2AADC0CFF9FA778"><enum>(b)</enum><header>Exception</header><text display-inline="yes-display-inline">Subsection (a) shall not apply to the portion of the final rule that makes modifications to subpart B of part 8 of title 42, Code of Federal Regulations (relating to accreditation of opioid treatment programs).</text></subsection></section> 
</legis-body></bill>

